Addition of formoterol Turbuhaler® to budesonide Turbuhaler® is safe and well tolerated in the long-term treatment of mild asthma: results from the OPTIMA trial

P. M O'Byrne, P. J Barnes, R. Rodriguez-Roisin, T. Sandström, A. E. Tattersfield, E. M Runnerström, K. Svensson (Hamilton, ON, Canada; London, Nottingham, United Kingdom; Barcelona, Spain; Umea, Lund, Sweden)

Source: Annual Congress 2001 - Asthma and COPD management in primary care
Session: Asthma and COPD management in primary care
Session type: Poster Discussion
Number: 2198
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. M O'Byrne, P. J Barnes, R. Rodriguez-Roisin, T. Sandström, A. E. Tattersfield, E. M Runnerström, K. Svensson (Hamilton, ON, Canada; London, Nottingham, United Kingdom; Barcelona, Spain; Umea, Lund, Sweden). Addition of formoterol Turbuhaler® to budesonide Turbuhaler® is safe and well tolerated in the long-term treatment of mild asthma: results from the OPTIMA trial. Eur Respir J 2001; 16: Suppl. 31, 2198

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Addition of formoterol Turbuhaler® to budesonide Turbuhaler® increases the time to first severe exacerbation in long-term treatment of mild asthma: results from OPTIMA
Source: Eur Respir J 2001; 18: Suppl. 33, 517s
Year: 2001

Cost-effectiveness of budesonide and formoterol in a single inhaler compared to fluticasone in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 157s
Year: 2001

Safety of formoterol by Turbuhaler(R) as reliever medication compared with terbutaline in moderate asthma
Source: Eur Respir J 2002; 20: 859-866
Year: 2002



Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Does Clickhaler match the Turbuhaler for efficacy of inhaled budesonide?
Source: Eur Respir J 2005; 26: Suppl. 49, 339s
Year: 2005

Budesonide and formoterol in a single inhaler is safe and effective in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001

Early and sustained benefits of budesonide and formoterol in a single inhaler vs fluticasone in moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 157s
Year: 2001

Bronchodilator therapy with indacaterol once-daily in COPD: a 52-week comparison with formoterol
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Same minimal effective dose of budesonide Turbuhaler® and fluticasone Diskus®/Accuhaler® in adult asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 158s
Year: 2001

The anti-inflammatory effect of budesonide 800 μg/day via Easyhaler® compared with the same dose of budesonide via Turbuhaler® in adult asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

Treatment of acute severe asthma with formoterol Turbuhaler provides a similar effect on patients' well-being as salbutamol by pMDI plus spacer
Source: Eur Respir J 2002; 20: Suppl. 38, 47s
Year: 2002

Efficacy, safety and cost of budesonide/formoterol in a single inhaler compared with budesonide plus formoterol as separate inhalers
Source: Eur Respir J 2002; 20: Suppl. 38, 43s
Year: 2002

Once daily ciclesonide delivered via pMDI is effective and safe for the treatment of mild-to-moderate persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 208s
Year: 2006

Safety and tolerability of high-dose formoterol via aerolizer and salbutamol via MDI in patients with mild-to-moderate COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma
Source: Eur Respir J 2007; 29: 682-689
Year: 2007



Formoterol turbuhaler is effective and safe compared with salbutamol by pMDI and spacer as reliever therapy in patients with acute severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Budesonide 800 μg/day via Easyhaler® is as safe and effective as the same dose of budesonide via Turbuhaler® in adult asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 100s
Year: 2001

Cost-effectiveness of formoterol turbuhaler versus salbutamol as reliever therapy in asthma: results from the RELIEF worldwide randomised effectiveness study
Source: Eur Respir J 2002; 20: Suppl. 38, 43s
Year: 2002

Non-inferiority comparison of formoterol HFA (FM-HFA) pMDI with formoterol CFC (FM-CFC) pMDI in patients with symptomatic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 358s
Year: 2007

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone
Source: Eur Respir J 2001; 18: 262-268
Year: 2001